Par is investing in the future of the Rochester facility and this new production suite provides a major advancement in aseptic technology and operational excellence, allowing to continue the legacy of producing high-quality products well into the future. Utilizing advanced aseptic facility design philosophies and innovative technology, this fully integrated production suite allows for concurrent, multiproduct manufacturing while maintaining the highest levels of control to avoid cross environmental contamination and product mixups.
To support the production of high-quality products, the design process must begin with the end in mind. At the onset of design, the project team took the time to consider the end-state of the facility and to define the design parameters which the facility would follow. Consideration was given to operational requirements, regulatory compliance and quality assurance. As a result, the facility design has many features that aid in maintaining a compliant environment as well as encouraging good manufacturing behaviors.
Par embraced a sustainability approach, wanting to adapt the existing legacy facility to modern production requirements despite the space available for new construction at the Rochester site. Par has shown how an existing facility can be adapted for not only this initial renovation, but for future improvements as well.
Region: AmericasCountry: United StatesOffice: Blue Bell, PA
Services: Strategic & Facility Master Planning, Process, Architecture, Process ArchitectureIndustries: Aseptic, PharmaceuticalFacility Type: Manufacturing
Sr. Compliance Consultant/Sr. Vice President Compliance
Jason S. Collins, AIA
Director of Process Architecture
Gene Martini, PE
Senior Vice President, Engineering
Paul F. Valerio
Director, Process Technology
Sr. Director, CQV Operations